Fletcher SA, Cole AP, Lu C, et al. - Researchers utilized the Surveillance, Epidemiology, and End Results registry and the National Cancer Data Base to determine how the patient's insurance status (privately insured, insured by Medicaid, or uninsured) can influence outcomes such as diagnosis with advanced disease, cancer-specific survival, delay in treatment longer than 90 days, treatment in a high-volume hospital, and receipt of neoadjuvant chemotherapy. They selected people younger than 65 years who received the diagnosis of bladder cancer from 2007 to 2014. The likelihood of being diagnosed with muscle-invasive bladder cancer was approximately twice in uninsured and Medicaid-insured people in comparison to those with private insurance. Findings revealed worse prognoses and poorer care quality for uninsured and Medicaid-insured individuals vs privately insured people. To attenuate the burden of this disease, it may be helpful to expand high-quality insurance coverage to marginalized populations.